Full Text View
Tabular View
No Study Results Posted
Related Studies
Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy
This study has been terminated.
( Unable to accrue patients at a reasonable rate )
Study NCT01580618   Information provided by Kaiser Permanente

First Received on September 17, 2010.   Last Updated on April 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pleural Effusion
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Pleural Diseases
Respiratory Tract Diseases
Interventions listed in this trial
normal saline
TNK (Tenecteplase)
Additional drug interventions recognized in this trial
Tenecteplase
Tissue Plasminogen Activator
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Kaiser Permanente
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services